(Q41246280)

English

Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

1 reference

based on heuristic

inferred from title

author name string

Tae Eun Park

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Jameela Yusuff

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Roopali Sharma

3

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

publication date

7 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

International Journal of STD & AIDS

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

447-452

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

HIV infection and the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Recent developments regarding human immunodeficiency virus infection and stroke

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

HIV-associated lipodystrophy: from fat injury to premature aging

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Ten-year predicted coronary heart disease risk in HIV-infected men and women.

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Cardio- and cerebrovascular events in HIV-infected persons.

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Aspirin is indicated for primary prevention of cardiovascular events in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

The association of smoking with medical treatment adherence in the workforce of a large employer

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.

1 reference

https://api.crossref.org/works/10.1177%2F0956462415585448

21 January 2018

Identifiers

10.1177/0956462415585448

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41246280&oldid=2095324368"